The three RAS genes (HRAS, NRAS and KRAS), hereafter collectively referred to as oncogenic RAS, are the most frequently mutated driver proto-oncogenes in cancer, with KRAS being the most prevalent. This evidence concerns the gene KRAS and cancer.